| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |